SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

Exclusion Criteria

• •Change to regular asthma medication in 4-weeks prior to visit 1.
• •Use of oral, depot or parenteral corticosteroids within 8 weeks of visit 1.
• •Lower respiratory tract within 4 weeks of Visit 1
• •Received investigational study drug within 4 weeks of visit
• •Smoking history of \>10 pack years of more.
• •Serious uncontrolled disease.
• •Medical conditions or medications known to affect the assessments or endpoints.
• •Evidence of alcohol or drug abuse.
• •Known pregnancy or planned pregnancy.
• •Known or suspected hypersensitivity to inhaled corticosteroids, beta-agonists or lactose.
• •Previous enrollment in the study